The emerging approach of this peptide represents a exciting advance in the management of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide295150.thenerdsblog.com/48146386/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment